EUMOVATE

This brand name is authorized in Hong Kong, Ireland, Malta, New Zealand, Turkey, United Kingdom, South Africa

Active ingredients

The drug EUMOVATE contains one active pharmaceutical ingredient (API):

1 Clobetasone UNII 8U0H6XI6EO - CLOBETASONE BUTYRATE

Clobetasone is a topical corticosteroids. Clobetasone has little effect on hypothalamo-pituitary-adrenal function. Clobetasone is less potent than other available corticosteroid preparations and has been shown not to suppress the hypothalamo-pituitary-adrenal axis in patients treated for psoriasis or eczema. Read about Clobetasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EUMOVATE Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AB01	Clobetasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II)
Discover more medicines within D07AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 175586, 19270, 19271, 19273, 19275, 19276
Country: HK	Department of Health Drug Office	Identifier(s): 06945
Country: IE	Health Products Regulatory Authority	Identifier(s): 23116, 23124
Country: MT	Medicines Authority	Identifier(s): MA192/03901
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12457, 2394
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522350810, 8699522356522, 8699522380824, 8699522386581
Country: ZA	Health Products Regulatory Authority	Identifier(s): J/13.4.1/187, J/13.4.1/188